4.6 Article

Circulating Syndecan-1 as a Predictor of Persistent Thrombocytopenia and Lethal Outcome: A Population Study of Patients With Suspected Sepsis Requiring Intensive Care

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Endothelial Dysfunction is Associated With Increased Incidence, Worsened Severity, and Prolonged Duration of Acute Kidney Injury After Severe Trauma

Gabrielle E. Hatton et al.

Summary: Elevated levels of sTM and syndecan-1, indicating endothelial dysfunction, were found to be associated with higher incidence, worsened severity, and prolonged duration of AKI after severe trauma. Treatments targeting the stabilization of endothelium show promise for AKI treatment in severely injured patients.

SHOCK (2021)

Article Anesthesiology

Plasma concentrations of syndecan-1 are dependent on kidney function

Robert G. Hahn et al.

Summary: The renal elimination of syndecan-1 and heparan sulfate varies greatly and changes in kidney function may lead to several-fold changes in their plasma concentrations. This is commonly seen after trauma and major surgery.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2021)

Article Critical Care Medicine

Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS

Arianna Piotti et al.

Summary: Septic shock is characterized by endothelial damage and breakdown of the glycocalyx. Circulating markers such as SYN-1, S1P, and VE-cadherin are associated with disease severity and prognosis. Albumin supplementation has shown efficacy in reducing levels of VE-cadherin and improving outcomes in septic shock patients.

CRITICAL CARE (2021)

Review Critical Care Medicine

Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation

Takashi Ito et al.

Summary: Endothelial cells play a crucial role in maintaining vascular patency through their anticoagulant properties, which can be compromised under septic conditions, leading to aberrant activation of coagulation.

CRITICAL CARE (2021)

Review Pharmacology & Pharmacy

Soluble syndecans: biomarkers for diseases and therapeutic options

Jessica Bertrand et al.

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Review Critical Care Medicine

The glycocalyx: a novel diagnostic and therapeutic target in sepsis

Ryo Uchimido et al.

CRITICAL CARE (2019)

Article Medicine, Research & Experimental

Tie2 protects the vasculature against thrombus formation in systemic inflammation

Sarah J. Higgins et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Hematology

Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis

Maria E. Johansen et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)

Article Biochemistry & Molecular Biology

The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis

Eric P. Schmidt et al.

NATURE MEDICINE (2012)